The polymer, called polyethylene glycol or PEG, works by "fusing" the membranes of damaged nerve cells, and it can be applied up to eight hours after the injury without adversely affecting the patient ...

PEG-Naloxol (NKTR-118) in Phase II clinical trials. Clinical benefit has already been demonstrated with polymer–drug conjugates bearing classical chemotherapeutic agents. The future of cancer ...

Fast-scanning atomic force microscopy imaging of the molecule at two different time points shows positional shifts along the polymer chain on the left. On the right, the molecular structure of PEG ...

Their coating of a non-degradable polymer opens opportunities for particles ... To examine the effect of PEG surface attachment on particle diffusion, Wang and colleagues used a microscopy ...

"Although PEG@α-CD polypseudorotaxane is widely used, the structural changes that occur as α-CD rings shuttle along the polymer chain remain poorly understood. By revealing its structure at the ...

Imaging the PEG 100k @α-CD polypseudorotaxane showed a significantly longer (499.6 nm on average) and a more rigid structure, with the end-cap formations preventing the α-CD rings from slipping off.